Dave Jones

Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients

Highland is a global alternative fixed income manager that specializes in bank loans, high yield credit, distressed debt, structured products, real assets, and long-short equities, with a global geographic reach. The firm’s investment philosophy is rooted in a value-oriented, long-term approach, which combines bottom-up research with top-down technical market analysis. Their analysts follow a rigorous and time-tested bottom-up credit analysis for each credit they manage. Highland is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors.

Develops, manufactures, sells and markets biopharmaceutical products

Functions as a College/University

Goldman Sachs Capital Partners focuses on investments globally. It seeks long-term capital appreciation by committing equity to high-quality companies with superior management in a variety of situations, including LBOs, recapitalizations, stressed/distressed investments and growth investments to fund acquisition or expansion with an investment size ranging from $50 to $800 million and above. The firm invests across a range of industries in different forms of private equity instruments. Individual transactions vary considerably by industry, overall capital structure, geography, currency, stage of development, size and exit strategy.

Provides complex acute and post-acute care services

Coppermine capital invests in companies located in the United States with an enterprise value of USD 10 - 150 million. The firm targets companies across healthcare services, business services, food & beverage and niche manufacturing. It provides financing for early and growth stage capital requirements.

Provides financial services